Bank of New York Mellon »

Regulus Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Regulus Therapeutics (RGLS) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Regulus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Regulus Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regulus Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-09-30 $235k 149k 1.57
2024-06-30 $352k 197k 1.79

More positions owned by Bank of New York Mellon

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cap (GOOGL)
Alphabet Inc-cl C Cap (GOOG)
Broadcom (AVGO)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Inc - A Cl A (MA)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Bank of New York Mellon

Top funds holding Regulus Therapeutics

Federated Investors
NEA Management Company
Octagon Capital Advisors
BlackRock
Vanguard Group
BlackRock
Deep Track Capital
T. Rowe Price Associates
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Woodline Partners
DAFNA Capital Management
Point72 Asset Management
RA Capital Management

View all funds holding Regulus Therapeutics